Compare NVAX & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | SPNS |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.4B |
| IPO Year | 1995 | 1992 |
| Metric | NVAX | SPNS |
|---|---|---|
| Price | $6.87 | $43.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $10.78 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 3.9M | 397.1K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.07 | 1.15 |
| Revenue | ★ $1,064,651,000.00 | $564,331,000.00 |
| Revenue This Year | $58.91 | $8.80 |
| Revenue Next Year | N/A | $6.98 |
| P/E Ratio | ★ $3.34 | $37.67 |
| Revenue Growth | ★ 20.27 | 4.71 |
| 52 Week Low | $5.01 | $23.69 |
| 52 Week High | $11.55 | $43.36 |
| Indicator | NVAX | SPNS |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 68.47 |
| Support Level | $6.56 | $43.27 |
| Resistance Level | $7.03 | $43.36 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 81.33 | 91.12 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.